Pfizer, BioNTech to submit emergency authorization request to FDA Friday for COVID-19 vaccine

Pfizer and partner BioNTech announced they will submit a request on Friday to the U.S. Food and Drug Administration for emergency use authorization of their COVID-19 vaccine candidate. ABC News